RGC NASDAQ
Regencell Bioscience Holdings Limited
1W: -28.6%
1M: +20.3%
3M: +32.0%
YTD: -63.7%
1Y: -53.1%
3Y: +1839.0%
5Y: +1623.3%
$7.46
+0.70 (+10.36%)
Weekly Expected Move ±18.4%
$5
$6
$8
$9
$10
Credit Risk of going bust: lower than 59% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Regencell Bioscience Holdings Limited would be worth roughly what it owes.
Total debt $296K against a stock market value of $3.35B.
Distance to default 6.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $236K (short-term plus half of long-term), stock volatility 141.6%; Altman Z'' 2.39. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $296K against a stock market value of $3.35B.
Distance to default 6.08 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $236K (short-term plus half of long-term), stock volatility 141.6%; Altman Z'' 2.39. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.7B
52W Range4.51-69
Volume255,131
Avg Volume299,898
Beta1.43
Dividend—
Analyst Ratings
Company Info
CEOYat-Gai Au
Employees10
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-07-16
Websiteregencellbioscience.com
Chinachem Leighton Plaza
Hong Kong KY1-1107
HK
Hong Kong KY1-1107
HK
852 2155 0823
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Latest News
Regencell Bioscience Holdings (RGC) Looks Pricey On DOJ Probe And Internal Control Concerns - Simply Wall Street
Regencell Bioscience Holdings Limited Estimates – NASDAQ:RGC - TradingView
RGC Mar 2027 12.500 put (RGC270319P00012500) stock price, news, quote and history - Yahoo Finance UK
Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions
Regencell (RGC) Stock Looks Rich As DOJ Probe Raises Questions - Yahoo Finance Singapore
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| LO MARGARET HOOR HAN | 0 | — | 2026-03-18 | |
| AU YAT-PUI | 0 | — | 2026-03-18 | |
| AU YAT-GAI | 0 | — | 2026-03-18 | |
| LO WILLIAM WING YAN | 592,230 | $0.84 | 2026-03-18 | |
| LO MARGARET HOOR HAN | 592,230 | $17.40 | 2026-03-18 |